- Home
- ORGO vs RM Comparison
ORGO vs RM Comparison
Compare ORGO & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORGO | RM |
|---|---|---|
| Founded | 1985 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.6M | 390.4M |
| IPO Year | 2016 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ORGO | RM |
|---|---|---|
| Price | $2.63 | $30.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $7.67 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 686.0K | 43.7K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | ★ 1600.00 | 7.49 |
| EPS | 0.15 | ★ 4.45 |
| Revenue | $564,169,000.00 | ★ $645,598,000.00 |
| Revenue This Year | N/A | $12.83 |
| Revenue Next Year | $17.84 | $7.93 |
| P/E Ratio | $17.67 | ★ $7.07 |
| Revenue Growth | ★ 17.04 | 9.70 |
| 52 Week Low | $2.61 | $25.41 |
| 52 Week High | $7.08 | $46.00 |
Technical Indicators
Market Signals| Indicator | ORGO | RM |
|---|---|---|
| Relative Strength Index (RSI) | 23.16 | 35.00 |
| Support Level | $2.61 | $26.63 |
| Resistance Level | $5.08 | $35.24 |
| Average True Range (ATR) | 0.22 | 1.42 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 0.66 | 2.49 |
Price Performance
Historical ComparisonAbout ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.